About Pear Therapeutics:
Pear Therapeutics is the leader in prescription digital therapeutics (PDT). We aim to redefine medicine by discovering, developing, and delivering clinically validated, software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurological conditions. Our lead product, reSET®, for the treatment of Substance Use Disorder, was the first prescription digital therapeutic to receive marketing authorization from FDA to treat a disease. Pear’s second product, reSET-O®, for the treatment of Opioid Use Disorder, received marketing authorization from FDA in December 2018. Somryst®, developed for the treatment of chronic insomnia, was our third product to receive marketing authorization from FDA. For more information, visit us at www.peartherapeutics.com.
SUMMARY:
As Clinical Director, SUD/OUD, you will participate in the cross functional development of digital therapeutics in Pear’s substance use disorder/opioid use disorder program. The Clinical Director provides crucial clinical input into the mechanisms of actions and features incorporated into a digital therapeutic and is responsible for its early clinical development. In addition, this role provides clinical input and support for regulatory authority submissions and to the commercialization of authorized products. Open, effective, and proactive communication is critical for success in this role. This position reports to the VP, Research and Development.